Etiology

  • Most etiopathologic studies cluster schizoaffective disorder together with schizophrenia or bipolar disorder. As such, there is no specific pathophysiology that is ascribed exclusively to this disorder.

  • Genetic data suggest that chromosome 1q42 (near DISC1 gene location) and the BDNF gene may be associated with schizoaffective disorder.[9][10]

Pathophysiology

  • Patients present with deficits of information processing, similar to those of patients with schizophrenia, and deficits of emotional regulation, similar to those of patients with bipolar disorder.[4]

  • Reductions in both the gray and white matter, predominantly in the frontal and temporal regions, as well as in the hippocampus and parahippocampal gyri, have been reported.[4]

  • Various electrophysiologic abnormalities have been reported: abnormal event-related potentials (P50, N100, P300, contingent negative variation, and others), abnormal localization of sensory-evoked magnetic fields, abnormal middle-ear muscle activity, and abnormal eye movements.[4]

  • Neurochemical abnormalities: cerebrospinal fluid norepinephrine, prostaglandin E1 (PGE1), norepinephrine, PGE1-stimulated adenylate cyclase, and platelet 5-hydroxytryptamine (5-HT) levels are similar among patients with schizoaffective disorder and schizophrenia, while platelet 5-HT profiles are similar among patients with schizoaffective disorder and bipolar disorder.[11]

Use of this content is subject to our disclaimer